{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-085425","form_type":"8-K","ticker":"CGEM","cik":"0001789972","company_name":"Cullinan Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.734663+00:00","generated_at":"2026-05-19T10:58:53.635575+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cullinan Therapeutics annual meeting results: all proposals pass, directors elected","bullets":["Elected Class II directors: Anthony Rosenberg, David P. Ryan, Mary Thistle; each received >47M votes for.","Ratified KPMG as independent auditor for FY2025: 51.9M for, 157K against, 14K abstain.","Approved advisory say-on-pay on executive compensation: 46.96M for, 2.00M against, 14.7K abstain.","Stockholders voted for annual say-on-pay frequency (48.5M for 1 year); board adopts annual vote."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-085425","json":"https://secwatch.observer/filing/0000950170-25-085425.json","markdown":"https://secwatch.observer/filing/0000950170-25-085425.md","text":"https://secwatch.observer/filing/0000950170-25-085425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/0000950170-25-085425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025085425/cgem-20250612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:58:53.635575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}